Increasing the targeting scope and precision of next-generation gene editing technology

The Pin-point™ base editing platform features a novel three-part design that offers the flexibility to "mix and match" individual system components.

Read this application note to learn more about the unique modularity of the Pin-point base editing system as a novel nucleaseagnostic modular platform for increasing the targeting scope and precision of next‑generation gene editing technology.

In this application note, you will learn about…

• Advantages of the Pin-point platform for addressing difficult-to-reach genomic targets
• How the Pin-point platform provides a novel nucleaseagnostic modular approach for increasing the targeting scope and precision of next‑generation gene editing technology
• How it allows for simple and fast evaluation of RNA-guided nucleases, deaminases, various guide RNA designs, and aptamer combinations

The Pin-point platform technology is available for clinical study and commercialization under a commercial license from Revvity. Pin-point reagents are available for research use only.